Table 1.
Demographic profiles (n = 31).
Fig 1.
Displayed are Swiss cantons and their populations per km2. The number of patients (in black) are displayed per canton.
Table 2.
Prevalence in Switzerland (n = 35).
Table 3.
Clinical features at disease onset and at inclusion.
Fig 2.
Disease activity and medication.
Disease activity (A) and medication of each patient over time (years) (B). 27/31 patients were followed prospectively up to 3 years. DMARDs: Disease-modifying antirheumatic drugs.
Fig 3.
Pattern of vessel involvement of 31 TAK patients as determined by imaging and/or clinical findings.
Table 4.
Angiographic type (n = 31).